Wells Fargo Raises Iovance Biotherapeutics Price Target to $18.00
Wells Fargo analyst initiated coverage on Iovance Biotherapeutics with a price target of $18.00, up from $14.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Wells Fargo raises IOVA price target to $18
Wells Fargo raised its price target for IOVA to $18.